UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)

PloS one, 2012-02, Vol.7 (2), p.e31900-e31900

2012

Volltextzugriff (PDF)

PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases

International journal of molecular sciences, 2019-11, Vol.20 (22), p.5792

2019

Volltextzugriff (PDF)

Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer

Biomolecules (Basel, Switzerland), 2022-07, Vol.12 (7), p.928

2022

Volltextzugriff (PDF)

Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment

Cancers, 2018-10, Vol.10 (10), p.375

2018

Volltextzugriff (PDF)

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex

Orphanet journal of rare diseases, 2020-08, Vol.15 (1), p.209-209, Article 209

2020

Volltextzugriff (PDF)

Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis

BioMed research international, 2015-01, Vol.2015, p.315240-14

2015

Volltextzugriff (PDF)

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

PloS one, 2016-04, Vol.11 (4), p.e0152584-e0152584

2016

Volltextzugriff (PDF)

Translation initiation factor eIF2a serine 51 phosphorylation couples with the mammalian target of rapamycin (mTOR) to determine cell fate and tumorigenesis under stress

European journal of cancer (1990), 2016-12, Vol.69, p.S141

Koromilas, A

2016

Volltextzugriff (PDF)

p53-mediated autophagic regulation: A prospective strategy for cancer therapy

Cancer letters, 2015-07, Vol.363 (2), p.101-107

2015

Volltextzugriff (PDF)

Insights into Overlappings of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis

Iranian journal of allergy, asthma, and immunology, 2023-04, Vol.22 (2), p.190

2023

Volltextzugriff (PDF)

Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice

Marine drugs, 2021-03, Vol.19 (4), p.193

2021

Volltextzugriff (PDF)

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

Cancer letters, 2015-05, Vol.361 (1), p.112-120

2015

Volltextzugriff (PDF)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Cell & bioscience, 2020-03, Vol.10 (1), p.31-31, Article 31

2020

Volltextzugriff (PDF)

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer

PloS one, 2021-04, Vol.16 (4), p.e0248380-e0248380

2021

Volltextzugriff (PDF)

mTOR Signaling Network in Cell Biology and Human Disease

International journal of molecular sciences, 2022-12, Vol.23 (24), p.16142

2022

Volltextzugriff (PDF)

AKAP13 couples GPCR signaling to mTORC1 inhibition

PLoS genetics, 2021-10, Vol.17 (10), p.e1009832-e1009832

2021

Volltextzugriff (PDF)

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy

Cancers, 2022-11, Vol.14 (22), p.5520

2022

Volltextzugriff (PDF)

Targeting mTOR and Metabolism in Cancer: Lessons and Innovations

Cells (Basel, Switzerland), 2019-12, Vol.8 (12), p.1584

2019

Volltextzugriff (PDF)

Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation

International journal of molecular sciences, 2024-01, Vol.25 (2), p.1331

2024

Volltextzugriff (PDF)

ATF4 in the Control of Liver Metabolism Downstream of Anabolic and Stress Signals

Byles, Vanessa Ann

2020

Volltextzugriff (PDF)

Targeting the mTOR Signaling Pathway Utilizing Nanoparticles: A Critical Overview

Cancers, 2019-01, Vol.11 (1), p.82

2019

Volltextzugriff (PDF)

Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?

Cancers, 2022-12, Vol.14 (24), p.6141

2022

Volltextzugriff (PDF)

New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response

Cancers, 2018-03, Vol.10 (3), p.78

2018

Volltextzugriff (PDF)

The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat

PloS one, 2017-12, Vol.12 (12), p.e0189514-e0189514

2017

Volltextzugriff (PDF)

The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10651

2023

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

KollektionPublisher site

ThemaCancer

ThemaKinases

ThemaProteins

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(114)
Dissertationen
(1)

Sprache

Englisch
(115)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

11 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(18)
Cancers
(15)
International Journal Of Molecular Sciences
(12)
Cells
(6)
Cancer Cell International
(5)
Cancer Letters
(5)
Biomolecules
(3)
Cell & Bioscience
(3)
Disease Models & Mechanisms
(3)
Plos Genetics
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)

PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases

Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer

Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex

Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

Translation initiation factor eIF2a serine 51 phosphorylation couples with the mammalian target of rapamycin (mTOR) to determine cell fate and tumorigenesis under stress

p53-mediated autophagic regulation: A prospective strategy for cancer therapy

Insights into Overlappings of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis

Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer

mTOR Signaling Network in Cell Biology and Human Disease

AKAP13 couples GPCR signaling to mTORC1 inhibition

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy

Targeting mTOR and Metabolism in Cancer: Lessons and Innovations

Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation

ATF4 in the Control of Liver Metabolism Downstream of Anabolic and Stress Signals

Targeting the mTOR Signaling Pathway Utilizing Nanoparticles: A Critical Overview

Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?

New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response

The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat

The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics

Aktive Filter

Suchergebnisse filtern